A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

Sharad A Ghamande, M. Silverman, M. Gold

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalGynecologic Oncology
Volume114
Issue number1
DOIs
StatePublished - Jul 1 2009

Fingerprint

Controlled Clinical Trials
Placebos
Safety
Drug Therapy
Ovarian epithelial cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

@article{245db4ba3d2b4fd898b9af7f89517e3d,
title = "A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer",
author = "Ghamande, {Sharad A} and M. Silverman and M. Gold",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.ygyno.2009.03.012",
language = "English (US)",
volume = "114",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

AU - Ghamande, Sharad A

AU - Silverman, M.

AU - Gold, M.

PY - 2009/7/1

Y1 - 2009/7/1

UR - http://www.scopus.com/inward/record.url?scp=67349174252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349174252&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2009.03.012

DO - 10.1016/j.ygyno.2009.03.012

M3 - Letter

AN - SCOPUS:67349174252

VL - 114

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -